BioCentury
ARTICLE | Clinical News

BC-819: Phase I/II start

February 2, 2009 8:00 AM UTC

In 1H09, BioCancell will begin an international Phase I/IIa trial to evaluate intraperitoneal BC-819 in 12 patients. ...